Del 85 - Advances in Pharmacology

Drug-Induced Liver Injury

Inbunden, Engelska, 2019

3 549 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more.

Includes the authority and expertise of leading contributors in pharmacology
Presents the latest release in the Advances in Pharmacology series

Produktinformation

Utgivningsdatum2019-07-13
Mått152 x 229 x undefined mm
Vikt610 g
FormatInbunden
SpråkEngelska
SerieDel 85 i Advances in Pharmacology
Antal sidor288
FörlagElsevier Science
ISBN9780128167595

Tillhör följande kategorier

Hepatologi inom Medicin
Farmakologi inom Medicin

Anup Ramachandran is at University of Kansas Medical Center, KS, USA Dr. Hartmut Jaeschke, PhD, is the University Distinguished Professor and Chairman of the Department of Pharmacology, Toxicology, and Therapeutics at the University of Kansas Medical Center, Kansas City, Kansas. He joined KUMC in 2006. He is a Fellow of the Academy ofToxicological Sciences and Fellow of the American Association for the Study of Liver Diseases. He has published more than 470 peer-reviewed manuscripts, invited reviews, and book chapters in the areas of liver toxicology and liver pathophysiology. He currently serves as an AssociateEditor for Toxicological Sciences, the inaugural Editor-in-Chief of Livers (since 2020), and is a member of 14 editorial boards. In 2019, he was the recipient of the Translational Impact Award from the Society of Toxicology. His major research interests include basic mechanisms and translational aspects of xenobiotic-induced hepatotoxicity and tissue repair with a focus on acetaminophen overdose and mechanisms of inflammatory liver injury in animal models and humans.

1. Primary hepatocytes and their cultures for the testing of drug-induced liver injury Vânia Vilas-Boas, Axelle Cooreman, Eva Gijbels, Raf Van Campenhout, Emma Gustafson, Steven Ballet, Pieter Annaert, Bruno Cogliati and Mathieu Vinken2. Cell death in drug-induced liver injuryAndrea Iorga and Lily Dara3. Drug-induced liver injury in obesity and nonalcoholic fatty liver diseaseJulien Allard, Dounia Le Guillou, Karima Begriche and Bernard Fromenty4. Role and mechanisms of autophagy in alcohol-induced liver injuryXiaojuan Chao and Wen-Xing Ding5. Mechanisms of idiosyncratic drug-induced liver injuryJack Uetrecht6. Idiosyncratic drug-induced liver injury in patients: detection, severity assessment, and regulatory implicationsPaul B. Watkins7. Acetaminophen hepatotoxicity: A mitochondrial perspectiveAnup Ramachandran and Hartmut Jaeschke8. Biomarkers of drug-induced liver injuryMitchell R. McGill and Hartmut Jaeschke9. Mechanisms and biomarkers of liver regeneration after drug-induced liver injuryMelissa M. Clemens, Mitchell R. McGill and Udayan Apte10. Evaluation and treatment of acetaminophen toxicityErik S. Fisher and Steven C. Curry